Cell 167:843857.e814 Ethics declarations Funding This work was supported in part by Deutsches Zentrum fr Diabetesforschung (DZD), Alexander von Humboldt Foundation, Helmholtz Alliance ICEMED through the Initiative and Networking Fund of the Helmholtz Association, and the Helmholtz cross-program topic Metabolic Dysfunction
Hold the pen like a dart in your dominant hand
Clinical trials have demonstrated that weekly dulaglutide administration provides glycemic control comparable to once-daily liraglutide, while offering improved adherence and patient convenience
An important note for the research community: afamelanotide is the INN (International Non-proprietary Name) assigned to Melanotan 1 following clinical development
On the supply side, key figures such as CEOs, vice presidents, directors of marketing and sales, directors of technology and innovation, and other important leaders were interviewed by industry experts